Filing Details
- Accession Number:
- 0001104659-23-087440
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-03 20:27:11
- Reporting Period:
- 2023-08-01
- Accepted Time:
- 2023-08-03 20:27:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1657312 | Verona Pharma Plc | VRNA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1836883 | A. Kathleen Rickard | 3 More London Riverside London X0 SE1 2RE | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2023-08-01 | 19,736 | $2.68 | 2,966,400 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2023-08-02 | 13,728 | $2.59 | 2,952,672 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- These sales were effected pursuant to a Rule 10b5-1 instruction entered into on May 14, 2021 solely with the intent to cover taxes in connection with the vesting of certainly previously reported Restricted Share Units.
- The price reported represents the sale price of the ADSs divided by eight (8).
- Consists of (i) 1,551,792 Ordinary Shares underlying RSUs (which are represented by 193,974 ADSs); and (ii) 1,400,880 Ordinary Shares underlying 175,110 ADSs.